Biodexa Pharmaceuticals PLC: Preliminary Results for the Year Ended 31 December 2023 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Adhera Therapeutics, Inc. (OTCMKTS:ATRX – Get Free Report) was the target of a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 14,600 shares, a growth of 7,200.0% from the December 31st total of 200 shares. Based on an average trading volume of 317,100 shares, […]
Biodexa Announces Closing Of $6 0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Biodexa Pharmaceuticals PLC, , a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announced the.
Biodexa Announces Closing Of $6 0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.